As the 2004 Presidential election nears, the issue of human cloning and embryonic stem cell research is under intense debate

NewsGuard 100/100 Score

As the 2004 Presidential election nears, the issue of human cloning and embryonic stem cell research is under intense debate and the stakes are tremendous.

The United Nations, headed by Secretary General Kofi Annan is currently debating two proposals: one from Costa Rica and supported by the U.S. and sixty-two other countries that would ban all human cloning, and another from Belgium and twenty-one other countries that would allow cloning of human embryos but not their transfer to a womb. Instead, the embryos would be sacrificed for scientific research.

This week, Dr. David Prentice, Senior Fellow for Life Science at Family Research Council met with a variety of yet undecided countries to gain support of a global ban on human cloning. Slovakia, Nigeria, Kenya, Norway, Ethiopia, Philippines and Uganda are the latest to join the alliance of countries speaking out on behalf of the global ban.

"This is a crucial issue," says Dr. Prentice, "Will we follow a path that allows creation of human life for experiments, creating a caste system of lesser humans for scientific sacrifice? Or will we value every human life, especially the most vulnerable?"

Some U.N. countries, including the Muslim bloc, have expressed the desire to delay a decision on the global ban, until after the U.S. elections. Their hope is that if elected, Sen. Kerry, who is on record supporting human cloning for research, will tip the balance at the U.N. and eliminate the United States as a powerful force against human cloning.

http://www.frc.org/

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Triple-negative breast cancer patients with high immune cell levels have lower relapse risk after surgery